Skip to main content

Advertisement

SpringerLink
Log in

MAGE-A antigens in lesions of the oral mucosa

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Oral squamous cell carcinoma develops continuously out of predamaged oral mucosa. For the physician and pathologist, difficulties arise in distinguishing precancerous from cancerous lesions. MAGE-A antigens are tumor antigens that are found solely in malignant transformed cells. These antigens might be useful in distinguishing precancerous from cancerous lesions. The aim of this study was to verify this assumption by comparing MAGE-A expression in benign, precancerous, and cancerous lesions of the oral mucosa. Retrospectively, biopsies of different oral lesions were randomly selected. The lesions that were included are 64 benign oral lesions (25 traumatic lesions (oral ulcers), 13 dental follicles, and 26 epulis), 26 oral lichen planus, 123 epithelial precursor lesions (32 epithelial hyperplasia found in leukoplakias, 24 epithelial dysplasia found in leukoplakias, 26 erythroplasia with oral epithelial dysplasia, and 41 carcinomas in situ in erythroleukoplakias). The lesions were immunohistochemically stained with the poly-MAGE-A antibody 57B, and the results were compared. Biopsies of oral lichen planus, oral ulcers, dental follicles, epulis, and leukoplakia without dysplasia showed no positive staining for MAGE-A antigens. Leukoplakia with dysplasia, dysplasia, and carcinomata in situ displayed positive staining in 33%, 65%, and 56% of the cases, respectively. MAGE-A antigens were not detectable via immunohistochemistry in benign lesions of the oral mucosa. The staining rate of dysplastic precancerous lesions or malignant lesions ranged from 33% to 65%. The MAGE-A antigens might facilitate better differentiation between precancerous and cancerous lesions of the oral mucosa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW (2008) Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44:1345–1389

    Article  PubMed  Google Scholar 

  2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592

    Article  PubMed  Google Scholar 

  3. Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe, 2004. Ann Oncol 16:481–488

    Article  PubMed  Google Scholar 

  4. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C (2003) Mortality from major cancer sites in the European Union, 1955–1998. Ann Oncol 14:490–495

    Article  PubMed  Google Scholar 

  5. Bagan JV, Scully C (2008) Recent advances in Oral Oncology 2007: epidemiology, aetiopathogenesis, diagnosis and prognostication. Oral Oncol 44:103–108

    Article  PubMed  Google Scholar 

  6. Folz BJ, Silver CE, Rinaldo A, Fagan JJ, Pratt LW, Weir N, Seitz D, Ferlito A (2008) An outline of the history of head and neck oncology. Oral Oncol 44:2–9

    Article  PubMed  Google Scholar 

  7. Lung T, Tascau OC, Almasan HA, Muresan O (2007) Head and neck cancer, treatment, evolution and post therapeutic survival—part 2: a decade's results 1993–2002. J Cranio-maxillo-facial Surg 35:126–131

    Article  Google Scholar 

  8. Gondos A, Arndt V, Holleczek B, Stegmaier C, Ziegler H, Brenner H (2007) Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer 121:395–400

    Article  PubMed  Google Scholar 

  9. Reichart PA (2007) Orale Leukoplakie/Erythroplakie. Stellungnahme der Deutschen Gesellschaft für Zahn-, Mund- und Kieferheilkunde (DGZMK). Dtsch Zahnarztl Z 62:45–48

    Google Scholar 

  10. Scheifele C, Reichart PA (2003) Is there a natural limit of the transformation rate of oral leukoplakia? Oral Oncol 39:470–475

    Article  PubMed  Google Scholar 

  11. Driemel O, Hertel K, Reichert TE, Kosmehl H (2006) Aktuelle Klassifikation der Präkursorläsionen des oralen Plattenepithelkarzinoms. Prinzipien der WHO-Klassifikation 2005. Mund Kiefer Gesichtschir 10:89–93

    Article  PubMed  Google Scholar 

  12. Gale N, Pilch BZ, Sidransky D, Westra WH, Califano J (2005) Epithelial precursor lesions. IARC, Lyon

    Google Scholar 

  13. Batzler WU GK, Hentschel S, Husmann G, Kaatsch P, Katalanic A, Kieschke J, Kraywinkel K, Meyer M, Stabenow R, Stegmaier C, Bertz J, Hberland J, Wolf U (2008) Krebs in Deutschland 2003–2004. Häufigkeiten und Trends. Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg), Berlin

  14. Bray I, Brennan P, Boffetta P (2000) Projections of alcohol- and tobacco-related cancer mortality in Central Europe. Int J Cancer 87:122–128

    Article  PubMed  Google Scholar 

  15. Rosenquist K (2005) Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Swed Dent J Suppl 179:1–66

    PubMed  Google Scholar 

  16. Rosenquist K, Wennerberg J, Annertz K, Schildt EB, Hansson BG, Bladstrom A, Andersson G (2007) Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors. Acta Otolaryngol 127:980–987

    Article  PubMed  Google Scholar 

  17. Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Fabianova E, Rudnai P, Brennan P (2007) Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol 165:814–820

    Article  PubMed  Google Scholar 

  18. Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L, Wunsch-Filho V, Franceschi S, Hayes RB, Herrero R, Koifman S, La Vecchia C, Lazarus P, Levi F, Mates D, Matos E, Menezes A, Muscat J, Eluf-Neto J, Olshan AF, Rudnai P, Schwartz SM, Smith E, Sturgis EM, Szeszenia-Dabrowska N, Talamini R, Wei Q, Winn DM, Zaridze D, Zatonski W, Zhang ZF, Berthiller J, Boffetta P (2007) Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 99:777–789

    Article  PubMed  Google Scholar 

  19. Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Janout V, Fabianova E, Bencko V, Moullan N, Chabrier A, Hung R, Hall J, Canzian F, Brennan P (2006) Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 15:696–703

    Article  PubMed  Google Scholar 

  20. Boffetta P, Hashibe M, La Vecchia C, Zatonski W, Rehm J (2006) The burden of cancer attributable to alcohol drinking. Int J Cancer 119:884–887

    Article  PubMed  Google Scholar 

  21. Reichart PA, Philipsen HP (2005) Oral erythroplakia—a review. Oral Oncol 41:551–561

    Article  PubMed  Google Scholar 

  22. El Naggar A, Reichart PA (2005) Proliferative verrucous leukoplakia and precancerous conditions. IARC Press, Lyon

    Google Scholar 

  23. Driemel O, Kunkel M, Hullmann M, von Eggeling F, Muller-Richter U, Kosmehl H, Reichert TE (2007) Diagnosis of oral squamous cell carcinoma and its precursor lesions. J Dtsch Dermatol Ges 5:1095–1100

    Article  PubMed  Google Scholar 

  24. Reibel J (2003) Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 14:47–62

    Article  PubMed  Google Scholar 

  25. Scanlan MJ, Simpson AJ, Old LJ (2004) The cancer/testis genes: review, standardization, and commentary. Cancer Immun 4:1

    PubMed  Google Scholar 

  26. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT (2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188:22–32

    Article  PubMed  Google Scholar 

  27. Muller-Richter UD, Dowejko A, Zhou W, Reichert TE, Driemel O (2008) Different expression of MAGE-A-antigens in foetal and adult keratinocyte cell lines. Oral Oncol 44:628–633

    Article  PubMed  Google Scholar 

  28. Ries J, Vairaktaris E, Mollaoglu N, Wiltfang J, Neukam FW, Nkenke E (2008) Expression of melanoma-associated antigens in oral squamous cell carcinoma. J Oral Pathol & Med 37:88–93

    Article  Google Scholar 

  29. Ries J, Schultze-Mosgau S, Neukam F, Diebel E, Wiltfang J (2005) Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy. Int J Oncol 26:817–824

    PubMed  Google Scholar 

  30. Rimoldi D, Salvi S, Schultz-Thater E, Spagnoli GC, Cerottini JC (2000) Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family. Int J Cancer 86:749–751

    Article  PubMed  Google Scholar 

  31. Lee KD, Eura M, Ogi K, Nakano K, Chikamatsu K, Masuyama K, Ishikawa T (1996) Expression of the MAGE-1, -2, -3, -4, and -6 genes in non-squamous cell carcinoma lesions of the head and neck. Acta Otolaryngol 116:633–639

    Article  PubMed  Google Scholar 

  32. Hudolin T, Juretic A, Spagnoli GC, Pasini J, Bandic D, Heberer M, Kosicek M, Cacic M (2006) Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue. Prostate 66:13–18

    Article  PubMed  Google Scholar 

  33. Tamura G (2006) Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 12:192–198

    PubMed  Google Scholar 

  34. Müller-Richter UD, Dowejko A, Peters S, Rauthe S, Reuther T, Gattenlöhner S, Reichert TE, Driemel O, Kübler AC (2009) MAGE-A antigens in patients with primary oral squamous cell carcinoma. Clin Oral Investig. 2 June 2009 [Epub ahead of print]

  35. Müller-Richter UDA, Dowejko A, Reuther T, Kleinheinz J, Reichert TE, Driemel O (2008) Analysis of expression profiles of MAGE-A antigens in oral squamous cell carcinoma cell lines. Head Face Med 5:10

    Article  Google Scholar 

  36. Driemel O, Dahse R, Berndt A, Pistner H, Hakim SG, Zardi L, Reichert TE, Kosmehl H (2007) High-molecular tenascin-C as an indicator of atypical cells in oral brush biopsies. Clin Oral Investig 11:93–99

    Article  PubMed  Google Scholar 

Download references

Conflict of interests

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, Pleicherwall 2, 97070, Würzburg, Germany

    Eva Krauss, Tobias Reuther, Michael Kochel, Ulrike Kriegebaum, Alexander C. Kübler & Urs D. A. Müller-Richter

  2. Institute of Pathology, University Hospital Würzburg, Josef-Schneider-Straße 2, 97080, Würzburg, Germany

    Stephan Rauthe & Stefan Gattenlöhner

Authors
  1. Eva Krauss
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephan Rauthe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefan Gattenlöhner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tobias Reuther
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael Kochel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ulrike Kriegebaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alexander C. Kübler
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Urs D. A. Müller-Richter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Urs D. A. Müller-Richter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krauss, E., Rauthe, S., Gattenlöhner, S. et al. MAGE-A antigens in lesions of the oral mucosa. Clin Oral Invest 15, 315–320 (2011). https://doi.org/10.1007/s00784-010-0387-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-010-0387-9

Keywords

Search

Navigation